Bafna Pharmaceuticals Ltd. - Research Center
532989 BAFNAPH Group (T) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sales | 115.35 | 85.14 | 71.22 | 42.47 | 43.36 |
| Operating profit | 15.72 | 11.49 | 10.30 | 1.23 | -13.34 |
| Interest | 2.04 | 0.79 | 0.74 | 0.10 | 2.13 |
| Gross profit | 16.95 | 12.80 | 10.31 | 1.39 | -14.81 |
| EPS (Rs) | 4.79 | 2.18 | 2.46 | -106.54 | -8.34 |
Annual
results in details
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Other income | 3.27 | 2.10 | 0.75 | 0.26 | 0.65 |
| Stock adjustment | -2.91 | -1.77 | 2.95 | -3.24 | 0.81 |
| Raw material | 59.57 | 53.06 | 42.51 | 30.24 | 33.29 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 15.87 | 14.50 | 11.98 | 10.25 | 9.01 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 27.11 | 7.86 | 3.48 | 3.99 | 13.58 |
| Provisions made | - | - | - | - | - |
| Depreciation | 5.33 | 5.49 | 4.48 | 3.27 | 3.42 |
| Taxation | 0.28 | - | - | - | 1.50 |
| Net profit / loss | 11.34 | 5.15 | 5.83 | -25.20 | -19.73 |
| Extra ordinary item | - | -2.16 | - | -23.33 | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 23.66 | 23.66 | 23.66 | 2.37 | 23.66 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 13.62 | 13.50 | 14.46 | 2.89 | -30.76 |
| GPM (%) | 14.29 | 14.67 | 14.32 | 3.25 | -33.64 |
| NPM (%) | 9.56 | 5.90 | 8.10 | -58.99 | -44.83 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis